INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2024

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

The components of the provision for income taxes for the years ended December 31, 2024 and 2023 consisted of the following:

	Years Ended December 31,
	2024		2023
Current tax provision
Federal	$	—	$	—
State	93		2
Total current tax provision	93		2
Deferred tax provision
Federal	(4)		1
State	(18)		9
Total deferred tax provision	(22)		10
Total income tax provision	$	71	$	12

The reconciliation of taxes at the federal statutory rate to the provision for income taxes for the years ended December 31, 2024 and 2023 was as follows:

	Years Ended December 31,
	2024		2023
Tax at statutory federal rate	$	(201,214)	$	(181,041)
State tax, net of federal benefit	(76,530)		(70,917)
Stock-based compensation	6,404		23,822
Section 162(m) limitation	9		3,551
Divestiture of affiliate	—		(11,776)
Research and development credits, net of uncertain tax position	—		(13,822)
Warrant revaluation	(3)		(109)
Change in fair value of convertible debt instruments	4,014		60,204
Non-deductible interest expense	4,203		16,666
Net operating loss	6,918		—
Other	(405)		12,572
Change in valuation allowance	256,675		160,862
Total income tax provision	$	71	$	12

Schedule of Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities as of December 31, 2024 and 2023 consisted of the following:

	As of December 31,
	2024		2023
Deferred tax assets:
Federal and state income tax credits	$	8,334	$	66,692
Net operating loss carryforward	72,218		397,340
Start-up costs capitalized	1,612		1,655
Stock-based compensation	5,827		4,659
Finance lease liabilities	33,650		32,202
Inventory	8,140		21,999
Research expenditures	89,370		79,429
Warranty reserve	19,237		23,072
Accrued Settlement Costs	38,331		—
Property, plant and equipment	44,816		—
Intangible assets	19,867		—
Other	2,881		2,429
Total deferred tax assets	344,283		629,477
Valuation allowance	(341,005)		(597,680)
Deferred tax assets, net of valuation allowance	3,278		31,797
Deferred tax liabilities:
Intangible assets	—		(2,775)
Finance lease assets	(3,278)		(1,860)
Property, plant and equipment, net	—		(27,184)
Total deferred tax liabilities	(3,278)		(31,819)
Deferred tax liabilities, net	$	—	$	(22)

Schedule of Unrecognized Tax Benefits Roll Forward

The following table reflect changes in the unrecognized tax benefits:

	Years Ended December 31,
	2024		2023
Gross amount of unrecognized tax benefits as of the beginning of the year	$	22,764	$	18,076
Additions based on tax positions related to the current year	—		4,677
Additions based on tax position from prior years	(911)		11
Gross amount of unrecognized tax benefits as of the end of the year	$	21,853	$	22,764

Schedule Of Net Operating Losses And R&D Credit Carryforwards Valuation Allowances

The decrease in the valuation allowance for the year ended December 31, 2024 of $256.7 million as reflected below, is primarily due to write offs of limited NOLs and R&D credits that would never be realized by the company due to Section 382 limitations.

	Years Ended December 31,
	2024		2023
Valuation Allowance as of the beginning of the period	$	(597,680)	$	(435,923)
Current Year Change	256,675		(161,757)
Valuation Allowance as of the end of the period	$	(341,005)	$	(597,680)